Prospective case-specific cohort study of surgical versus nonsurgical treatment in patients with lung cancer with spinal metastases

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100048151

Enrollment

Unknown

Registered

2021-07-04

Start date

2021-07-01

Completion date

Unknown

Last updated

2022-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal metastases from lung cancer

Interventions

Two groups:Surgery versus non-surgery treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Definitely diagnosed as lung cancer with spinal metastases; 2. Surgical treatment, non-surgical treatment (including chemoradiotherapy, chemotherapy, molecular targeted therapy or other anti-tumor therapy); 3. Agree to participate in the study, cooperate in the completion of follow-up, and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Primary spinal tumor; 2. Tumor metastasis in other sites; 3. Without any medical treatment.

Design outcomes

Primary

Measure	Time frame
Life Time;	—

Countries

China

Contacts

Public ContactWei Feng

Peking University Third Hospital

weifeng@bjmu.edu.cn+86 13911230265

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 10, 2026